Arcturus Therapeutics Ltd. Net Change in Cash
Arcturus Therapeutics Ltd. reported Net Change in Cash of -$5.49 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2019-05-13
- Arcturus Therapeutics Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was -$5.49M, a 149.19% decline year-over-year.
- Arcturus Therapeutics Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2018-03-31 was $11.16M.
- Arcturus Therapeutics Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2018 was $11.58M, a 31.46% decline from fiscal 2017.
- Arcturus Therapeutics Ltd. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2017 was $16.89M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|
| 2019-03-31 | -$5.49M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $11.58M 10-K · filed 2019-03-18 | |
| 2018-03-31 | $11.16M 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $16.89M 10-K · filed 2019-03-18 |